Our news

  • Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the most frequently used medication to treat it. Several studies have investigated the benefits of methylphenidate, showing possible favourable effects on ADHD symptoms, but the true magnitude of the effect...
    May 10 2018
  • We are delighted to announce the appointment of Rebecca Syed as the new Deputy Coordinating Editor of Cochrane SchizophreniaSince graduating in medicine from Balliol College, Oxford University, Rebecca has become a board-certified psychiatrist in both the UK and Australia. She has lived and worked in clinical and research capacities in...
    May 10 2018
  • This Review from Cochrane Epilepsy found six clinical trials that included in analysis 1759 people with focal epilepsy. These trials were all randomised controlled trials (clinical studies where people were randomly put into one of two or more treatment groups) that compared the antiepileptic drug rufinamide (at doses between 200 mg per day and...
    April 30 2018
  • The Cochrane Developmental, Psychosocial and Learning Problems Group covers a wide range of topics relevant to the mental health of both adults and children in the more than 140 Cochrane Reviews it has produced to date. In March 2018, it added to these with a new review of cognitive-behavioural interventions for attention deficit hyperactivity...
    April 10 2018
  • A Cochrane Review published in October 2014 by Cochrane Epilepsy highlights current evidence about the intelligence of children born to women taking antiepileptic medication. One medication, valproate, is of particular concern as it is associated with a drop in IQ sufficient to impact on educational and employment opportunities. There was no...
    March 28 2018
  • World Alzheimer’s Day, September 21st of each year, is a day on which organizations around the world concentrate their efforts on raising awareness about Alzheimer’s and dementia. Alzheimer’s disease is the most common form of dementia, a group of disorders that impairs mental functioning.  Each year for World Alzheimer's Day, Cochrane...
    March 21 2018
  • Clinicians, patients, caregivers, researchers. We all have a role that we can play in Cochrane's work. We summarize the best available evidence to help people make informed decisions about health. Now you can join our independent network of Cochrane collaborators from over 130 countries producing credible, accessible health information in...
    February 2 2018
  • FAQs  Cochrane Brain, Nerves and Mind contact information
    February 2 2018
  • World Alzheimer's Day: 21 September The Recommended Dose: Episode 2 with Dr. Allen Frances Presenting evidence-based health information for people with MS
    February 2 2018
  • Cochrane Brain, Nerves and Mind supports the work of the nine Cochrane Review Groups focusing on research in the following areas: Common Mental Disorders Dementia and Cognitive Improvement Developmental, Psychosocial and Learning Problems Drugs and Alcohol Epilepsy Movement Disorders Multiple Sclerosis and Rare Diseases of the CNS Neuromuscular...
    February 2 2018

Pages

Subscribe to Our news